SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-064653
Filing Date
2023-05-25
Accepted
2023-05-25 16:31:03
Documents
12
Period of Report
2023-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316594d1_8k.htm   iXBRL 8-K 54604
  Complete submission text file 0001104659-23-064653.txt   230087

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anip-20230523.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20230523_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20230523_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2316594d1_8k_htm.xml XML 3464
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 23961218
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences